ImpaQ Ecosystem•Clarivate, Scopus & CORE Data
Clarivate WoS 2024 / 2025 Data
IMPAQ
WoS SCIE Q2Scopus Q2SCImago #6,314Hybrid

Journal of Pharmacokinetics and Pharmacodynamics

Abbreviation (ISO):J PHARMACOKINET PHAR
•
Identifier (ISSN):1567-567X(Print)/1573-8744(Online)
•
Publisher:Springer US
Clarivate IF (2026)
3.3↑ +0.5
Journal Impact Factor
IF Trend↓
WoS Quartile
Q2
WoS SCIEJCR Quartile
Clarivate WoS JCR
WoS Categories↓
JCR Release Date: 2026-06-17

Impact Factor Trend (2018–2026)

Clarivate IF trend for Journal of Pharmacokinetics and Pharmacodynamics

WoS Q2
12452.220182.9120192.4620202.7520212.4120222.520232.220242.820253.32026
Annual Impact Factor Metric
Current (2026):3.3
Scopus SJR & RankScopus Q2
0.85
#6,314

SCImago Journal Rank citation prestige weighting

Scopus Year: 2025
H-Index (2025)
77

77 papers with at least that number of citations each

WoS: SCIE / JCRQ2
Self-Citation Rate13.6%
Safe Level (< 15%)Warning Level (> 20%)
Self-citation below 15% indicates strong scholarly independence.
Volume & Open AccessHybrid
61articles/year
49.31% Gold OA•94.74% Original Research

Aims & Scope

Broadly speaking, the Journal of Pharmacokinetics and Pharmacodynamics covers the area of pharmacometrics. The journal is devoted to illustrating the importance of pharmacokinetics, pharmacodynamics, and pharmacometrics in drug development, clinical care, and the understanding of drug action. The journal publishes on a variety of topics related to pharmacometrics, including, but not limited to, clinical, experimental, and theoretical papers examining the kinetics of drug disposition and effects of drug action in humans, animals, in vitro, or in silico; modeling and simulation methodology, including optimal design; precision medicine; systems pharmacology; and mathematical pharmacology (including computational biology, bioengineering, and biophysics related to pharmacology, pharmacokinetics, orpharmacodynamics). Clinical papers that include population pharmacokinetic-pharmacodynamic relationships are welcome. The journal actively invites and promotes up-and-coming areas of pharmacometric research, such as real-world evidence, quality of life analyses, and artificial intelligence. The Journal of Pharmacokinetics and Pharmacodynamics is an official journal of the International Society of Pharmacometrics.

Topics Covered (Recognized by AI)
Medicine84.1%Biology78.1%Internal medicine71.2%Pharmacology60.2%Computer science56%Chemistry55.3%Bioinformatics53.9%Mathematics51.6%Pharmacokinetics48.6%Statistics39.6%Genetics35.8%Sociology33.6%Psychology33%Environmental health32.4%Demography32.2%Population31.7%Biochemistry30.5%Organic chemistry29.8%Physics29.3%Psychiatry25.7%Endocrinology24.6%Economics24.1%Pathology24%Machine learning23.8%
Primary Research Areas

WoS Categories & Quartiles

Detailed JCR / JCI category rankings and quartile breakdown from Clarivate

Clarivate JCR & JCI
JCRSCIE2026

PHARMACOLOGY & PHARMACY

Q2
Rank149/356
IndexSCIE
JCISCIE2026

PHARMACOLOGY & PHARMACY

Q2
Rank127/356
IndexSCIE

Annual Historical Statistics & Publications

Track annual publication volume, total citations, and Impact Factor evolution

12 year
2026Latest
IF3.3
Articles / Year50
Total Citations9
2025
IF2.8
Articles / Year57
Total Citations183
2024
IF2.2
Articles / Year58
Total Citations313
2023
IF2.5
Articles / Year56
Total Citations515
2022
IF2.41
Articles / Year42
Total Citations412

SCImago & Scopus Journal Intelligence

Global SCImago ranking, SJR prestige index, Scopus coverage, and societal policy impact

Rank #6,314Scopus Q2SCImago Profile
Scopus Coverage:1996-1997, 1999, 2001-2026
Scopus Broad Areas:Pharmacology, Toxicology and Pharmaceutics
Scopus Citation Rank (SJR)Q2
0.85

Weighted prestige citation metric per document indexed in the Scopus database.

Quartile: Scopus Q2
Citations / Doc (2 years)
2.95

Average citations received per document published in the 2-year window.

2-Year Citation Window
Estimated Publication Fee (APC)
$3,130 USD

Estimated Article Processing Charge for Open Access publication.

Estimated cost / article

Scopus 3-Year Publication & Citation Window

3-Year Citations458
3-Year Documents154
Citable Documents137

Aggregated from Scopus database across the 3-year SJR evaluation window.

Societal Impact & Inclusivity (SCImago)

Policy Citations (Overton)0

Citations in government and international policy documents

Female Author Rate39.5%

Percentage of female authors published in the journal

Real-world societal policy reach and author gender diversity tracked by SCImago.

Scopus Subject Categories

PharmacologyQ2
Academic Metric Intelligence

Journal Metrics & Citation Visualizations

Total Cites vs Self-Cites

Evaluation of scholarly independence and citation reach

Total citations steady growth
Self-citation: 13.6%

Citations per Document

Citation metric windows across 2, 3, and 4 years

Cites / Doc (4 years)Cites / Doc (3 years)Cites / Doc (2 years)

Chinese Academy of Sciences (CAS) Classification

Major / minor zone classification and CAS Early Warning List history

Major Category (Broad Field):
3区 (Zone 3)Medicine
Minor Category (Specific Field):
3区PHARMACOLOGY & PHARMACY
CAS Early Warning List History:
Updated annually: 2020 – 2024
2020
Not warned
2021
Not warned
2022
Not warned
2023
Not warned
2024
Not warned

Academic Intelligence Overview & Context

ImpaQ Analysis

Journal of Pharmacokinetics and Pharmacodynamics (abbr: J PHARMACOKINET PHAR, ISSN: 1567-567X) is a peer-reviewed international scholarly journal in the field of Medicine, published by Springer US in United States since 1973. The periodical holds a Journal Impact Factor (JIF) of 3.30, ranking in quartile Q2 of Web of Science (SCIE), a Scopus SJR indicator of 0.850 (Q2), an H-index of 77.

The journal enforces rigorous peer evaluation with a publication frequency of Bimonthly, an annual output of approximately 61 scientific articles. In terms of accessibility and author fees, it operates under the Hybrid model with an estimated APC of $3,130 USD. It serves as a benchmark publication platform for academics, researchers, and doctoral candidates seeking global research visibility.

Publishing & Editorial Information

Detailed publisher, peer-review turnaround, and publication cycle specifications

Open Access Model
Hybrid
Publisher
Springer US
Publication Language
English
Frequency
Bimonthly
Founding Year
1973
Indexing & Databases
SCIEScopusPubMed
Editorial Address
SPRINGER/PLENUM PUBLISHERS, 233 SPRING ST, NEW YORK, USA, NY, 10013

Similar Journals in Discipline

Journals in the same research field with comparable impact metrics

Record UUID: 376aa627-8001-425e-a786-984952f20f56
Database Updated: 2026-10-01